From: A novel predictive model for phthisis bulbi following facial hyaluronic acid cosmetic injection
Case No | Long-term complications at 2-year follow-up | Gender | Age | Involved eye | Interval from injury to long-term complication onset (months) | IOP at long-term complication onset (mmHg) | Follow-up duration (months) | Grade in NISS | Sequelae of ASI during 2 years of follow-up |
---|---|---|---|---|---|---|---|---|---|
1 | Hypotony | female | 28 | OS | 1 | 5 | 6 | 4 | mydriasis |
2 | PB | female | 27 | OD | 6 | 6 | 24 | 3 | iris atrophy of 360°circumference |
3 | PB | male | 31 | OD | 6 | 5.6 | 24 | 3 | iris atrophy of 360°circumference |
4 | PB | female | 42 | OD | 6 | 6.5 | 24 | 4 | iris atrophy of 360°circumference |
6 | PB | female | 18 | OS | 6 | 0 | 24 | 3 | iris atrophy of 1 quadrant |
13 | CHS | female | 44 | OS | 1 | 13.5 | 12 | 1 | iris atrophy of 1 quadrant |
16 | CHS | female | 30 | OD | 6 | 13.8 | 24 | 3 | mydriasis |
18 | PB | female | 31 | OD | 12 | 7.3 | 24 | 3 | iris atrophy of 360°circumference |
20 | Hypotony | female | 35 | OS | 6 | 6.8 | 24 | 3 | mydriasis |
22 | Hypotony | female | 44 | OS | 1 | 7.8 | 12 | 3 | iris atrophy of 1 quadrant |